Literature DB >> 19490100

Control of transforming growth factor beta signal transduction by small GTPases.

Dimitris Kardassis1, Carol Murphy, Theodore Fotsis, Aristidis Moustakas, Christos Stournaras.   

Abstract

The integrated roles of small GTPases in executing the transforming growth factor beta (TGFbeta) signaling pathway have attracted increasing attention in recent years. In this review, we summarize recent findings on TGFbeta signaling during receptor endocytosis, Smad trafficking and actin cytoskeleton remodeling, and emphasize the role of small GTPases in these processes. First, we give an overview of the different endocytic routes taken by TGFbeta receptors, their impact on active TGFbeta signaling versus degradation and their regulation by the small GTPases Rab, RalA/Ral-binding protein 1 and Rap2. Second, we focus on the mechanisms and regulation of Smad trafficking in the cytoplasm, through the nuclear pores and into the nucleus, and the contribution of Ran GTPase to these events. Third, we summarize the role of Rho small GTPases in early and late cytoskeleton remodeling in various cell models and diseases, and the positive and negative cross-talk between Rho GTPases and the TGFbeta/Smad pathway. The biological significance of this exciting research field, the perspectives and critical open questions are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490100     DOI: 10.1111/j.1742-4658.2009.07031.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  33 in total

1.  Cells lacking β-actin are genetically reprogrammed and maintain conditional migratory capacity.

Authors:  Davina Tondeleir; Anja Lambrechts; Matthias Müller; Veronique Jonckheere; Thierry Doll; Drieke Vandamme; Karima Bakkali; Davy Waterschoot; Marianne Lemaistre; Olivier Debeir; Christine Decaestecker; Boris Hinz; An Staes; Evy Timmerman; Niklaas Colaert; Kris Gevaert; Joël Vandekerckhove; Christophe Ampe
Journal:  Mol Cell Proteomics       Date:  2012-03-22       Impact factor: 5.911

2.  All-trans-retinoic acid promotes trafficking of human concentrative nucleoside transporter-3 (hCNT3) to the plasma membrane by a TGF-beta1-mediated mechanism.

Authors:  Paula Fernández-Calotti; Marçal Pastor-Anglada
Journal:  J Biol Chem       Date:  2010-02-19       Impact factor: 5.157

3.  Interleukin (IL)-6 modulates transforming growth factor-β receptor I and II (TGF-βRI and II) function in epidermal keratinocytes.

Authors:  Lerin R Luckett-Chastain; Mackenzie L Cottrell; Bethany M Kawar; Michael A Ihnat; Randle M Gallucci
Journal:  Exp Dermatol       Date:  2017-03-08       Impact factor: 3.960

Review 4.  Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.

Authors:  Eirini Nomikou; Melina Livitsanou; Christos Stournaras; Dimitris Kardassis
Journal:  Cell Mol Life Sci       Date:  2018-03-02       Impact factor: 9.261

Review 5.  Post-translational regulation of TGF-β receptor and Smad signaling.

Authors:  Pinglong Xu; Jianming Liu; Rik Derynck
Journal:  FEBS Lett       Date:  2012-05-19       Impact factor: 4.124

6.  Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.

Authors:  Tadashi Yasuda; Yuji Tada; Nobuhiro Tanabe; Koichiro Tatsumi; James West
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-19       Impact factor: 5.464

7.  Eccentric exercise activates novel transcriptional regulation of hypertrophic signaling pathways not affected by hormone changes.

Authors:  Lauren G MacNeil; Simon Melov; Alan E Hubbard; Steven K Baker; Mark A Tarnopolsky
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

8.  Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells.

Authors:  Igor Bryukhovetskiy; Valeriy Shevchenko
Journal:  Oncol Lett       Date:  2016-06-22       Impact factor: 2.967

9.  Expression and mutation analyses implicate ARHGAP29 as the etiologic gene for the cleft lip with or without cleft palate locus identified by genome-wide association on chromosome 1p22.

Authors:  Elizabeth J Leslie; M Adela Mansilla; Leah C Biggs; Kristi Schuette; Steve Bullard; Margaret Cooper; Martine Dunnwald; Andrew C Lidral; Mary L Marazita; Terri H Beaty; Jeffrey C Murray
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-09-24

10.  Further evidence suggesting a role for variation in ARHGAP29 variants in nonsyndromic cleft lip/palate.

Authors:  Ariadne Letra; Lorena Maili; John B Mulliken; Edward Buchanan; Susan H Blanton; Jacqueline T Hecht
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.